We are a fully integrated biopharmaceutical company dedicated to bringing promising therapeutics to patients in underserved therapeutic areas in China.
We started our business in 2001 collaborating with global pharmaceutical MNCs to distribute their products in China. Through years of collaboration with MNCs, we have developed full value chain capabilities that laid the foundation for our evolution into an integrated biopharmaceutical company.
With deep knowledge of the China market and recognition by MNC partners of our value chain capabilities, we have successfully acquired full product rights for a portfolio of de-risked drug assets to address China’s unmet medical needs and have evolved into a marketing authorization holder responsible for drug quality for their entire lifecycle.